Clinical Trial Update: Long Term Follow-up of Pegylated-Interferon Alpha-2b

View source ↗

Summary

This document provides long-term follow-up data from a completed clinical trial of pegylated interferon alfa-2b in chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Pegylated Interferon Alpha-2b (pegylated interferon alfa-2b)

Snippet

Sponsor: Foundation for Liver Research | Conditions: Chronic Hepatitis B | Status: COMPLETED